S5.12 In the blood: using circulating DNA to detect and monitor cancer
Genetics Unzipped
00:00
Canser Screening
The volumes of data we generate through ore workang through our clinical studies, dwarfs pretty much anything else that's out there in genomics right now. So thinking about applying this to cansas screening. We have national screening programs for cervical canser, at balcanser, for breast cancer. Can we pick them up earlier? There are several critical things when you think about the use of technology like this in population screening. You want to be able to detect as many counters as possible, but you want to do it with a very low false positive rate.
Transcript
Play full episode
